• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » INC Research names Carol Aliyar senior vice president, study start-up

INC Research names Carol Aliyar senior vice president, study start-up

July 17, 2014
CenterWatch Staff

INC Research, a global phase I to IV CRO has announced the promotion of Carol Aliyar to senior vice president, study start-up. Aliyar will be responsible for leading the company¹s global site engagement and study start-up efforts, including study start-up operations, site identification, site start-up and activation, ethics and regulatory submissions/approval and patient recruitment. Aliyar will focus on fostering strong site relationships to optimize timelines and deliver rapid study start-up for global clinical trials, establishing the foundation for successful collaboration across the duration of a study.

“Developing long-lasting relationships with clinical research sites is critically important to our ability to deliver best-in-class clinical development solutions for our customers,” said Alistair Macdonald, chief operating officer, INC Research. “Study start-up is an essential phase in this process, because it serves as the initial interaction point with sites and customers and defines the relationship for the duration of the trial.”

Prior to joining INC in September 2012 to lead site start-up and regulatory for Europe, Aliyar held senior management positions at global CROs and at an international biopharmaceutical company. INC Research’s team will deliver a personalized and integrated approach that optimizes the start-up experience through strengthened collaboration and improved information exchange with our site partners.

“With 48% of studies failing to meet enrollment targets and more than 11% unable to recruit a single patient, the industry faces many challenges today in trial execution,” said Aliyar. “My team is committed to establishing partnership principles with sites to ensure they are motivated and well supported to deliver on enrollment targets, which are vital to a study’s success.”

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing